Patents by Inventor Milind Rode

Milind Rode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBSTITUTED FUSED PYRIMIDINONE COMPOUNDS
    Publication number: 20190127381
    Abstract: Provided herein are novel fused pyrimidinone derivatives of Formula I and synthetic intermediates that are useful in preparing the compounds of formula (I). Further provided herein is a method for preparation of a compound of formula (I) or intermediates, a pharmaceutical composition comprising a compound of formula (I), and use of a compound of formula (I).
    Type: Application
    Filed: April 25, 2017
    Publication date: May 2, 2019
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Deepa JOSHI, Milind RODE, Sanjay SRIVASTAVA, Davinder TULI, Ramesh Chandra GUPTA, Deepak RAI, Prashant JAMADARKHANA, Shailesh DESHPANDE, Vivek MISHRA, Jaya ABRAHAM
  • Urea-substituted indanes as P38 map kinase inhibitors
    Patent number: 9963463
    Abstract: The present invention relates to novel indanyl urea derivatives of formula (I): their pharmaceutically acceptable salts, and their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the compounds for the preparation of medicament for use as pharmaceuticals.
    Type: Grant
    Filed: August 27, 2015
    Date of Patent: May 8, 2018
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Milind Rode, Sanjay Srivastava, Davindar Tuli, Deepak Rai, Prashant Gj, Shailesh Deshpande, Rameshchandra Gupta, Vijay Chauthaiwale, Chaitanya Dutt
  • P38 MAP KINASE INHIBITING INDANYL UREA COMPOUNDS
    Publication number: 20170247390
    Abstract: The present invention relates to novel indanyl urea derivatives, their pharmaceutically acceptable salts, and their isomers, stereoisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the compounds for the preparation of medicament for use as pharmaceuticals.
    Type: Application
    Filed: August 27, 2015
    Publication date: August 31, 2017
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Milind RODE, Sanjay SRIVASTAVA, Davindar TULI, Deepak RAI, Prashant GJ, Shailesh DESHPANDE, Rameshchandra GUPTA, Vijay CHAUTHAIWALE, Chaitanya DUTT
  • Thiazolinones and Oxazolinones and their Use as Ptp1b Inhibitors
    Publication number: 20090088432
    Abstract: The present invention encompasses; the novel substituted heterocyclic compounds represented by formula (I) or their pharmaceutically acceptable salts, wherein the substituents in formula (I) have the meanings as defined in the specification. The invention also encompasses process for preparing such compound, pharmaceutical compositions and methods of treating or preventing PTP-1B mediated diseases.
    Type: Application
    Filed: September 15, 2006
    Publication date: April 2, 2009
    Inventors: Rakesh Kumar Banerjee, Ramesh Chandra Gupta, Davinder Tuli, Milind Rode, Bharat Suthar, Dhananjay Umrani, Padmaja Pathak, Tejal Choksi, Anita Chaudhary